- Home
- KFRC vs CVAC Comparison
KFRC vs CVAC Comparison
Compare KFRC & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFRC
- CVAC
- Stock Information
- Founded
- KFRC 1962
- CVAC 2000
- Country
- KFRC United States
- CVAC Germany
- Employees
- KFRC N/A
- CVAC N/A
- Industry
- KFRC Professional Services
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- KFRC Consumer Discretionary
- CVAC Health Care
- Exchange
- KFRC Nasdaq
- CVAC Nasdaq
- Market Cap
- KFRC 770.2M
- CVAC 764.4M
- IPO Year
- KFRC 1995
- CVAC 2020
- Fundamental
- Price
- KFRC $40.10
- CVAC $5.44
- Analyst Decision
- KFRC Buy
- CVAC Buy
- Analyst Count
- KFRC 3
- CVAC 3
- Target Price
- KFRC $53.67
- CVAC $9.00
- AVG Volume (30 Days)
- KFRC 117.8K
- CVAC 2.1M
- Earning Date
- KFRC 07-28-2025
- CVAC 08-14-2025
- Dividend Yield
- KFRC 3.88%
- CVAC N/A
- EPS Growth
- KFRC N/A
- CVAC N/A
- EPS
- KFRC 2.56
- CVAC 0.87
- Revenue
- KFRC $1,383,447,000.00
- CVAC $566,039,775.00
- Revenue This Year
- KFRC N/A
- CVAC N/A
- Revenue Next Year
- KFRC $4.06
- CVAC $24.04
- P/E Ratio
- KFRC $15.73
- CVAC $6.34
- Revenue Growth
- KFRC N/A
- CVAC 787.60
- 52 Week Low
- KFRC $35.50
- CVAC $2.37
- 52 Week High
- KFRC $71.48
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- KFRC 43.86
- CVAC 68.03
- Support Level
- KFRC $39.23
- CVAC $4.07
- Resistance Level
- KFRC $41.05
- CVAC $5.58
- Average True Range (ATR)
- KFRC 0.91
- CVAC 0.20
- MACD
- KFRC -0.04
- CVAC 0.07
- Stochastic Oscillator
- KFRC 27.20
- CVAC 83.08
About KFRC Kforce Inc.
Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.